SeaStar Medical is trading at $2.90, down 5.23%, with broad market weakness the likeliest available context, not a confirmed catalyst.
- Current coverage surfaced no clear company-specific explanation for the October 16 decline; the CMO award announcement predates the move and does not establish a cause.
- The supplied market context shows the S&P 500 down 1.22% and Nasdaq down 2.27%, consistent with pressure across risk assets.
- Same-day trading volume details are inconclusive in available reports.